LY 544344

Known as: LY-544344, LY544344 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
Group II metabotropic glutamate receptors (mGluR2/3) are suggested to modulate anxiety, arousal, and stress including autonomic… (More)
  • figure 1
Is this relevant?
2010
2010
LY354740 is a potent mGlu2/3 agonist with a limited oral bioavailability. Its alanyl prodrug, LY544344, showed high affinity to… (More)
  • figure 1
  • figure 2
  • table 1
  • table 2
  • figure 3
Is this relevant?
2009
2009
The limited oral bioavailability of the potent and selective group II metabotropic glutamate (mGlu) 2/3 receptor agonist, (1S,2S… (More)
  • figure 1
  • figure 2
  • figure 4
  • figure 3
  • figure 5
Is this relevant?
Highly Cited
2008
Highly Cited
2008
LY354740, a potent and selective mGlu (metabotropic glutamate receptor)2/3 agonist, has shown efficacy in the treatment of… (More)
  • figure 1
  • table 1
  • figure 2
  • table 2
  • table 3
Is this relevant?
2007
2007
The peptidyl prodrug (1S,2S,5R,6S)-2-[(2'S)-(2-Amino)propionyl]a-minobicyclo[3.1.0.]hexen-2,6-dicarboxylic acid, also known as… (More)
  • figure 2
  • figure 1
  • table 1
  • table 2
  • figure 3
Is this relevant?
Review
2005
Review
2005
Eli Lilly and Co is developing LY-544344, a prodrug of the metabotropic glutamate receptor 2/3 agonist LY-354740, for the… (More)
Is this relevant?
2005
2005
Numerous studies have indicated that selective agonists of group II metabotropic glutamate (mGlu) receptors, such as LY354740… (More)
  • table 1
  • table 2
Is this relevant?
2005
2005
Numerous studies have indicated that selective agonists of group II metabotropic glutamate (mGlu) receptors, such as LY354740 and… (More)
  • table 1
Is this relevant?
2004
2004
Preclinical findings have repeatedly shown an anxiolytic-like action of agonists at metabotropic glutamate receptors type II… (More)
  • table 1
  • table 2
  • figure 1
  • figure 2
Is this relevant?